Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan
Author:
Funder
Pasteur Institute of Iran
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00280-019-03975-3.pdf
Reference64 articles.
1. Siegel RL, Miller KD (2016) Jemal A (2016) Cancer statistics. Cancer J Clin 66(1):7–30
2. Stein A, Atanackovic D, Bokemeyer C (2011) Current standards and new trends in the primary treatment of colorectal cancer. Eur J Cancer 47:S312–S314
3. Grothey A, Sargent D, Goldberg RM, Schmoll H-J (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22(7):1209–1214
4. Lan H, Li Y, Lin C-Y (2014) Irinotecan as a palliative therapy for metastatic breast cancer patients after previous chemotherapy. Asian Pac J Cancer Prev 15(24):10745–10748
5. Louafi S, Boige V, Ducreux M, Bonyhay L, Mansourbakht T, de Baere T, Asnacios A, Hannoun L, Poynard T, Taïeb J (2007) Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC). Cancer 109(7):1384–1390
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer;Digestive and Liver Disease;2024-02
2. Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-08
3. Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer;International Journal of Molecular Sciences;2022-12-20
4. Metabolomics studies of cell–cell interactions using single cell mass spectrometry combined with fluorescence microscopy;Chemical Science;2022
5. Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer;Acta Pharmaceutica Sinica B;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3